CD4 and neoplasm: Vaccination with tumor-derived cDC2s induced the Th17 polarization of CD4 T-cells, reprogramming of pro-tumor macrophages, and a decrease of myeloid-derived suppressor cells (MDSC)—resulting in tumor size reduction in a tumor mice model [47].